DNA diagnostics of the most common forms of monogenic diabetes in Slovakia

Mayer-Davis EJ, Kahkoska AR, Jefferies C et al. ISPAD Clinical Practice Consensus Guidelines 2018: Definition, epidemiology, and classification of diabetes in children and adolescents. Pediatr Diabetes 2018; 19(Suppl 27): Dostupné z DOI: <http://dx.doi.org/10.1111/pedi.12773>.

Hattersley A, Bruining J, Shield J et al. The diagnosis and management of monogenic diabetes in children and adolescents. Pediatr Diabetes 2009; 10(Suppl 12): 33–42. Dostupné z DOI: <http://dx.doi.org/10.1111/j.1399–5448.2009.00571.x>.

Thanabalasingham G, Pal A, Selwood MP et al. Systematic assessment of etiology in adults with a clinical diagnosis of young-onset type 2 diabetes is a successful strategy for identifying maturity-onset diabetes of the young. Diabetes Care 2012; 35(6):1206–1212. Dostupné z DOI: <http://dx.doi.org/10.2337/dc11–1243>.

Murphy R, Turnbull DM, Walker M et al. Clinical features, diagnosis and management of maternally inherited diabetes and deafness (MIDD) associated with the 3243A>G mitochondrial point mutation. Diabet Med 2008; 25(4): 383–399. Dostupné z DOI: <http://dx.doi.org/10.1111/j.1464–5491.2008.02359.x>.

Kanakatti Shankar R, Pihoker C, Dolan LM et al. Permanent neonatal diabetes mellitus: prevalence and genetic diagnosis in the SEARCH for Diabetes in Youth Study. Pediatr Diabetes 2013; 14(3): 174–180. Dostupné z DOI: <http://dx.doi.org/10.1111/pedi.12003>.

Slingerland AS, Shields BM, Flanagan SE et al. Referral rates for diagnostic testing support an incidence of permanent neonatal diabetes in three European countries of at least 1 in 260,000 live births. Diabetologia 2009; 52(8): 1683–1685. Dostupné z DOI: <http://dx.doi.org/10.1007/s00125–009–1416–6>.

Stanik J, Gasperikova D, Paskova M et al. Prevalence of permanent neonatal diabetes in Slovakia and successful replacement of insulin with sulfonylurea therapy in KCNJ11 and ABCC8 mutation carriers. J Clin Endocrinol Metab 2007; 92(4): 1276–1282. Dostupné z DOI: <http://dx.doi.org/10.1210/jc.2006–2490>.

McDonald TJ, Besser RE, Perry M et al. Screening for neonatal diabetes at day 5 of life using dried blood spot glucose measurement. Diabetologia 2017; 60(11): 2168–2173. Dostupné z DOI: <http://dx.doi.org/10.1007/s00125–017–4383–3>.

Vaxillaire M, Bonnefond A, Froguel P et al. Breakthroughs in monogenic diabetes genetics: from pediatric forms to young adulthood diabetes. Pediatr Endocrinol Rev 2009; 6(3): 405–417.

Murphy R, Ellard S, Hattersley AT. Clinical implications of a molecular genetic classification of monogenic beta-cell diabetes. Nat Clin Pract Endocrinol Metab 2008; 4(4): 200–213. Dostupné z DOI: <http://dx.doi.org/10.1038/ncpendmet0778>.

Colombo C, Geraci C, Suprani T et al. Macrosomia, transient neonatal hypoglycemia, and monogenic diabetes in a family with heterozygous mutation R154X of HNF4A gene. J Endocrinol Invest 2011; 34(3): 252–253. Dostupné z DOI: <http://dx.doi.org/10.1007/BF03347074>.

Pearson ER, Boj SF, Steele AM et al. Macrosomia and hyperinsulinaemic hypoglycaemia in patients with heterozygous mutations in the HNF4A gene. PLoS Med 2007; 4(4): e118. Dostupné z DOI: <http://dx.doi.org/10.1371/journal.pmed.0040118>.

Stanik J, Skopkova M, Brennerova K et al. Congenital hyperinsulinism and glycogenosis-like phenotype due to a novel HNF4A mutation. Diabetes Res Clin Pract 2017; 126: 144–150. Dostupné z DOI: <http://dx.doi.org/10.1016/j.diabres.2017.02.014>.

Katra B, Klupa T, Skupien J et al. Dipeptidyl peptidase-IV inhibitors are efficient adjunct therapy in HNF1A maturity-onset diabetes of the young patients--report of two cases. Diabetes Technol Ther 2010; 12(4): 313–316. Dostupné z DOI: <http://dx.doi.org/10.1089/dia.2009.0159>.

Fajans SS, Floyd JC, Tattersall RB et al. The various faces of diabetes in the young: changing concepts. Arch Intern Med 1976; 136(2): 194–202.

Stanik J, Dusatkova P, Cinek O et al. De novo mutations of GCK, HNF1A and HNF4A may be more frequent in MODY than previously assumed. Diabetologia 2014; 57(3): 480–484. Dostupné z DOI: <http://dx.doi.org/10.1007/s00125–013–3119–2>.

Tattersall RB. Mild familial diabetes with dominant inheritance. Q J Med 1974; 43(170): 339–357.

Ellard S, Bellanne-Chantelot C, Hattersley AT et al. Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young. Diabetologia 2008; 51(4): 546–553. Dostupné z DOI: <http://dx.doi.org/10.1007/s00125–008–0942-y>.

Valentinova L, Beer NL, Stanik J et al. Identification and functional characterisation of novel glucokinase mutations causing maturity-onset diabetes of the young in Slovakia. PLoS One 2012; 7(4): e34541. Dostupné z DOI: <http://dx.doi.org/10.1371/journal.pone.0034541>.

Shields BM, Hicks S, Shepherd MH et al. Maturity-onset diabetes of the young (MODY): how many cases are we missing? Diabetologia 2010; 53(12): 2504–2508. Dostupné z DOI: <http://dx.doi.org/10.1007/s00125–010–1799–4>.

Codner E, Rocha A, Deng L et al. Mild fasting hyperglycemia in children: high rate of glucokinase mutations and some risk of developing type 1 diabetes mellitus. Pediatr Diabetes 2009; 10(6): 382–388. Dostupné z DOI: <http://dx.doi.org/10.1111/j.1399–5448.2009.00499.x>.

Gloyn AL, van de Bunt M, Stratton IM et al. Prevalence of GCK mutations in individuals screened for fasting hyperglycaemia. Diabetologia 2009; 52(1): 172–174. Dostupné z DOI: <http://dx.doi.org/10.1007/s00125–008–1188–4>.

Javouhey E, Ranchin B, Lachaux A et al. Long-lasting extracorporeal albumin dialysis in a child with end-stage renal disease and severe cholestasis. Pediatr Transplant 2009; 13(2): 235–239. Dostupné z DOI: <http://dx.doi.org/10.1111/j.1399–3046.2008.00946.x>.

Chakera AJ, Spyer G, Vincent N et al. The 0.1% of the population with glucokinase monogenic diabetes can be recognized by clinical characteristics in pregnancy: the Atlantic Diabetes in Pregnancy cohort. Diabetes Care 2014; 37(5): 1230–1236. Dostupné z DOI: <http://dx.doi.org/10.2337/dc13–2248>.

Fendler W, Malachowska B, Baranowska-Jazwiecka A et al. Population-based estimates for double diabetes amongst people with glucokinase monogenic diabetes, GCK-MODY. Diabet Med 2014; 31(7): 881–883. Dostupné z DOI: <http://dx.doi.org/10.1111/dme.12449>.

Althari S, Gloyn AL. When is it MODY? Challenges in the Interpretation of Sequence Variants in MODY Genes. Rev Diabet Stud 2015; 12(3–4): 330–348. Dostupné z DOI: <http://dx.doi.org/10.1900/RDS.2015.12.330>.

Richards S, Aziz N, Bale S et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015; 17(5): 405–424. Dostupné z DOI: <http://dx.doi.org/10.1038/gim.2015.30>.

Bjorkhaug L, Sagen JV, Thorsby P et al. Hepatocyte nuclear factor-1 alpha gene mutations and diabetes in Norway. J Clin Endocrinol Metab 2003; 88(2): 920–931. Dostupné z DOI: <http://dx.doi.org/10.1210/jc.2002–020945>.

Rose RB, Bayle JH, Endrizzi JA et al. Structural basis of dimerization, coactivator recognition and MODY3 mutations in HNF-1alpha. Nat Struct Biol 2000; 7(9): 744–748. Dostupné z DOI: <http://dx.doi.org/10.1038/78966>.

Harries LW, Ellard S, Stride A et al. Isomers of the TCF1 gene encoding hepatocyte nuclear factor-1 alpha show differential expression in the pancreas and define the relationship between mutation position and clinical phenotype in monogenic diabetes. Hum Mol Genet 2006; 15(14): 2216–2224. Dostupné z DOI: <http://dx.doi.org/10.1093/hmg/ddl147>.

Gloyn AL, Odili S, Zelent D et al. Insights into the structure and regulation of glucokinase from a novel mutation (V62M), which causes maturity-onset diabetes of the young. J Biol Chem 2005; 280(14): 14105–14113. Dostupné z DOI: <http://dx.doi.org/10.1074/jbc.M413146200>.

Babiker T, Vedovato N, Patel K et al. Successful transfer to sulfonylureas in KCNJ11 neonatal diabetes is determined by the mutation and duration of diabetes. Diabetologia 2016; 59(6): 1162–1166. Dostupné z DOI: <http://dx.doi.org/10.1007/s00125–016–3921–8>.

Shepherd M, Shields B, Ellard S et al. A genetic diagnosis of HNF1A diabetes alters treatment and improves glycaemic control in the majority of insulin-treated patients. Diabet Med 2009; 26(4): 437–441. Dostupné z DOI: <http://dx.doi.org/10.1111/j.1464–5491.2009.02690.x>.

Shields BM, Spyer G, Slingerland AS et al. Mutations in the glucokinase gene of the fetus result in reduced placental weight. Diabetes Care 2008; 31(4): 753–757. Dostupné z DOI: <http://dx.doi.org/10.2337/dc07–1750>.

Spyer G, Hattersley AT, Sykes JE et al. Influence of maternal and fetal glucokinase mutations in gestational diabetes. Am J Obstet Gynecol 2001; 185(1): 240–241. Dostupné z DOI: <http://dx.doi.org/10.1067/mob.2001.113127>.